SHTDY:OTCMKTS
Sinopharm Group ADR
$9.36
arrow_upward
+0.35%(+0.033) 1D
Okt 2, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa SHTDY...
Buksan
$9.38
Mataas
$9.72
Mababa
$9.31
Mkt. cap
45.97B
Avg. na dami
193.41K
Dami
119.15K
Mataas nang 52-wk
$14.87
Mababa nang 52-wk
$9.05
Beta
0.10
Mga natitirang share
268.36M
Bilang ng mga empleyado
90K
Buksan
$9.38
Mataas
$9.72
Mababa
$9.31
Mkt. cap
45.97B
Avg. na dami
193.41K
Dami
119.15K
Mataas nang 52-wk
$14.87
Mababa nang 52-wk
$9.05
Beta
0.10
Mga natitirang share
268.36M
Bilang ng mga empleyado
90K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
24/7 Wall St.
·
1 araw ang nakalipas
The Stock Market Has Done This Only Once Before in the Last 156 Years. What Happens Next Gets Ugly Fast.
Barron's
·
23 oras ang nakalipas
A Scary Stock Market Divided Has Opened Up. Where It Goes Next.
MarketWatch
·
6 araw ang nakalipas
Micron could dethrone Nvidia and become the biggest driver of S&P 500 profit growth
Reuters
·
1 buwan ang nakalipas
S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
Profile
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Tungkol sa Sinopharm Group ADR